Mission: promote ovarian cancer awareness and education; support those diagnosed and survivors; and advocate for public policy and funding.
Tumor Profiling & Treatment Presentation
May 18, 5pm-6:15pm
Zoom Audio/Video (Login Information in Registration Confirmation)
Did you know that the genetic makeup of your tumor may influence the way your doctor treats your ovarian cancer?
Some tumors are genetically disposed to accumulate more errors than others, and that treating these types of tumors with a new class of drugs called PARP inhibitors may significantly reduce the cancers progression.
Please join us to learn more about how genetics and PARP inhibitors are being used to help patients.
There will be a Q&A segment after the presentation.
About the Presenters:
Dr. Sharyn N. Lewin, Medical Director, Division of Gynecologic Oncology, Holy Name Medical Center
Diana Turco, MS, CGC, Medical Science Liaison, Myriad Labs, myChoice CDx, EndoPredict, and Companion Diagnostics
Please note: login information will be included in event registration confirmation and event reminder emails. We are unable to monitor emails for login information during live events.
Ovarian Cancer Alliance of Oregon and Southwest Washington16420 SE McGillivray, Suite 103, PMB 243
Vancouver, WA 98683-3461
(877) 682-2679 email@example.com
We are a registered 501(c)(3) Non-Proft Corporation. EIN: 20-2558493Copyright © 2005-2019 Ovarian Cancer Alliance of Oregon and Southwest Washington. All rights reserved.